Skip to main navigation
Rapport Therapeutics, Inc. logo
  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Overview
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Committee Composition
  • Financial Information
    • SEC Filings
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact Us

Event Details

News & Events
  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Overview
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Committee Composition
  • Financial Information
    • SEC Filings
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact Us

RAP-219 Phase 2 in Bipolar Mania Topline Results

October 20, 2026 8:00 AM EDT

Click here for webcast

Supporting Materials

RAP-219 Phase 2 in Bipolar Mania Topline Results Presentation 1.4 MB

Investor Contact

drafts investors@rapportrx.com
© Rapport Therapeutics, Inc.
  • Link to LinkedIn opens in new window